866-997-4948(US-Canada Toll Free)

Global Growth Factors (Blood and Tissue) Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 107 Pages

This report studies the global market size of Growth Factors (Blood and Tissue) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Growth Factors (Blood and Tissue) in these regions.
This research report categorizes the global Growth Factors (Blood and Tissue) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia.
Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.
Growth factors are mainly used in the treatment of chronic diseases, such as anemia, renal disorders, cancer, etc. For instance, erythropoietin, which stimulates the growth of Red Blood Cells (RBCs), is used to treat anemia. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) are involved in the stimulation of White Blood Cells (WBCs) in cancer patients. However, abnormal production of growth factors causes several diseases.
In 2017, the global Growth Factors (Blood and Tissue) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Growth Factors (Blood and Tissue) market based on company, product type, application and key regions.

The various contributors involved in the value chain of Growth Factors (Blood and Tissue) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Growth Factors (Blood and Tissue) include
Amgen, Inc. (USA)
Bayer HealthCare Pharmaceuticals, Inc. (USA)
Biocon Ltd. (India)
Biogen, Inc. (USA)
BioMimetic Therapeutics LLC (USA)
Biopharm GmbH (Germany)
Bolder BioTechnology, Inc. (USA)
F. Hoffmann-La Roche AG (Switzerland)
Chugai Pharmaceutical Co. Ltd. (Japan)
Genentech, Inc. (USA)
FibroGen, Inc. (USA)
Johnson & Johnson (USA)
Janssen Biotech, Inc. (USA)
Lonza Group (Switzerland)
Merck Serono (Germany)
PeproTech, Inc. (USA)
Reliance GeneMedix Plc (UK)
Sangamo Therapeutics, Inc. (USA)
Sanofi (France)
Scil Proteins GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Wockhardt Ltd. (India)

Market Size Split by Type
Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Tissue Growth Factors
Market Size Split by Application
Hospital
Research lab

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Growth Factors (Blood and Tissue) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Growth Factors (Blood and Tissue) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Growth Factors (Blood and Tissue) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Growth Factors (Blood and Tissue) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Growth Factors (Blood and Tissue) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Growth Factors (Blood and Tissue) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Growth Factors (Blood and Tissue) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Growth Factors (Blood and Tissue) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Growth Factors (Blood and Tissue) Market Size Growth Rate by Type
1.4.2 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
1.4.3 Tissue Growth Factors
1.5 Market by Application
1.5.1 Global Growth Factors (Blood and Tissue) Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research lab
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Growth Factors (Blood and Tissue) Market Size
2.1.1 Global Growth Factors (Blood and Tissue) Revenue 2016-2025
2.1.2 Global Growth Factors (Blood and Tissue) Sales 2016-2025
2.2 Growth Factors (Blood and Tissue) Growth Rate by Regions
2.2.1 Global Growth Factors (Blood and Tissue) Sales by Regions
2.2.2 Global Growth Factors (Blood and Tissue) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Growth Factors (Blood and Tissue) Sales by Manufacturers
3.1.1 Growth Factors (Blood and Tissue) Sales by Manufacturers
3.1.2 Growth Factors (Blood and Tissue) Sales Market Share by Manufacturers
3.1.3 Global Growth Factors (Blood and Tissue) Market Concentration Ratio (CR5 and HHI)
3.2 Growth Factors (Blood and Tissue) Revenue by Manufacturers
3.2.1 Growth Factors (Blood and Tissue) Revenue by Manufacturers (2016-2018)
3.2.2 Growth Factors (Blood and Tissue) Revenue Share by Manufacturers (2016-2018)
3.3 Growth Factors (Blood and Tissue) Price by Manufacturers
3.4 Growth Factors (Blood and Tissue) Manufacturing Base Distribution, Product Types
3.4.1 Growth Factors (Blood and Tissue) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Growth Factors (Blood and Tissue) Product Category
3.4.3 Date of International Manufacturers Enter into Growth Factors (Blood and Tissue) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Growth Factors (Blood and Tissue) Sales by Type
4.2 Global Growth Factors (Blood and Tissue) Revenue by Type
4.3 Growth Factors (Blood and Tissue) Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Growth Factors (Blood and Tissue) Breakdown Data by Application

6 North America
6.1 North America Growth Factors (Blood and Tissue) by Countries
6.1.1 North America Growth Factors (Blood and Tissue) Sales by Countries
6.1.2 North America Growth Factors (Blood and Tissue) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Growth Factors (Blood and Tissue) by Type
6.3 North America Growth Factors (Blood and Tissue) by Application
6.4 North America Growth Factors (Blood and Tissue) by Company

7 Europe
7.1 Europe Growth Factors (Blood and Tissue) by Countries
7.1.1 Europe Growth Factors (Blood and Tissue) Sales by Countries
7.1.2 Europe Growth Factors (Blood and Tissue) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Growth Factors (Blood and Tissue) by Type
7.3 Europe Growth Factors (Blood and Tissue) by Application
7.4 Europe Growth Factors (Blood and Tissue) by Company

8 Asia Pacific
8.1 Asia Pacific Growth Factors (Blood and Tissue) by Countries
8.1.1 Asia Pacific Growth Factors (Blood and Tissue) Sales by Countries
8.1.2 Asia Pacific Growth Factors (Blood and Tissue) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Growth Factors (Blood and Tissue) by Type
8.3 Asia Pacific Growth Factors (Blood and Tissue) by Application
8.4 Asia Pacific Growth Factors (Blood and Tissue) by Company

9 Central & South America
9.1 Central & South America Growth Factors (Blood and Tissue) by Countries
9.1.1 Central & South America Growth Factors (Blood and Tissue) Sales by Countries
9.1.2 Central & South America Growth Factors (Blood and Tissue) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Growth Factors (Blood and Tissue) by Type
9.3 Central & South America Growth Factors (Blood and Tissue) by Application
9.4 Central & South America Growth Factors (Blood and Tissue) by Company

10 Middle East and Africa
10.1 Middle East and Africa Growth Factors (Blood and Tissue) by Countries
10.1.1 Middle East and Africa Growth Factors (Blood and Tissue) Sales by Countries
10.1.2 Middle East and Africa Growth Factors (Blood and Tissue) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Growth Factors (Blood and Tissue) by Type
10.3 Middle East and Africa Growth Factors (Blood and Tissue) by Application
10.4 Middle East and Africa Growth Factors (Blood and Tissue) by Company

11 Company Profiles
11.1 Amgen, Inc. (USA)
11.1.1 Amgen, Inc. (USA) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.1.4 Growth Factors (Blood and Tissue) Product Description
11.1.5 Recent Development
11.2 Bayer HealthCare Pharmaceuticals, Inc. (USA)
11.2.1 Bayer HealthCare Pharmaceuticals, Inc. (USA) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.2.4 Growth Factors (Blood and Tissue) Product Description
11.2.5 Recent Development
11.3 Biocon Ltd. (India)
11.3.1 Biocon Ltd. (India) Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.3.4 Growth Factors (Blood and Tissue) Product Description
11.3.5 Recent Development
11.4 Biogen, Inc. (USA)
11.4.1 Biogen, Inc. (USA) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.4.4 Growth Factors (Blood and Tissue) Product Description
11.4.5 Recent Development
11.5 BioMimetic Therapeutics LLC (USA)
11.5.1 BioMimetic Therapeutics LLC (USA) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.5.4 Growth Factors (Blood and Tissue) Product Description
11.5.5 Recent Development
11.6 Biopharm GmbH (Germany)
11.6.1 Biopharm GmbH (Germany) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.6.4 Growth Factors (Blood and Tissue) Product Description
11.6.5 Recent Development
11.7 Bolder BioTechnology, Inc. (USA)
11.7.1 Bolder BioTechnology, Inc. (USA) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.7.4 Growth Factors (Blood and Tissue) Product Description
11.7.5 Recent Development
11.8 F. Hoffmann-La Roche AG (Switzerland)
11.8.1 F. Hoffmann-La Roche AG (Switzerland) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.8.4 Growth Factors (Blood and Tissue) Product Description
11.8.5 Recent Development
11.9 Chugai Pharmaceutical Co. Ltd. (Japan)
11.9.1 Chugai Pharmaceutical Co. Ltd. (Japan) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.9.4 Growth Factors (Blood and Tissue) Product Description
11.9.5 Recent Development
11.10 Genentech, Inc. (USA)
11.10.1 Genentech, Inc. (USA) Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Growth Factors (Blood and Tissue)
11.10.4 Growth Factors (Blood and Tissue) Product Description
11.10.5 Recent Development
11.11 FibroGen, Inc. (USA)
11.12 Johnson & Johnson (USA)
11.13 Janssen Biotech, Inc. (USA)
11.14 Lonza Group (Switzerland)
11.15 Merck Serono (Germany)
11.16 PeproTech, Inc. (USA)
11.17 Reliance GeneMedix Plc (UK)
11.18 Sangamo Therapeutics, Inc. (USA)
11.19 Sanofi (France)
11.20 Scil Proteins GmbH (Germany)
11.21 Teva Pharmaceutical Industries Ltd. (Israel)
11.22 Wockhardt Ltd. (India)

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Growth Factors (Blood and Tissue) Raw Material
13.1.2 Growth Factors (Blood and Tissue) Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Growth Factors (Blood and Tissue)
Figure Global Growth Factors (Blood and Tissue) Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Growth Factors (Blood and Tissue) Production Market Share by Types (Product Category) in 2017
Figure Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) Product Picture
Table Major Manufacturers of Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Figure Tissue Growth Factors Product Picture
Table Major Manufacturers of Tissue Growth Factors
Table Global Growth Factors (Blood and Tissue) Market Size Growth Rate by Application 2018-2025 (MT)
Figure Hospital
Figure Research lab
Figure Growth Factors (Blood and Tissue) Report Years Considered
Figure Global Growth Factors (Blood and Tissue) Market Size 2016-2025 (Million US$)
Figure Global Growth Factors (Blood and Tissue) Sales 2016-2025 (MT)
Table Global Growth Factors (Blood and Tissue) Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Growth Factors (Blood and Tissue) Sales by Regions 2016-2025 (MT)
Table Global Growth Factors (Blood and Tissue) Sales Market Share by Regions 2016-2025
Figure Global Growth Factors (Blood and Tissue) Sales Market Share by Regions 2016-2025
Figure 2017 Global Growth Factors (Blood and Tissue) Sales Market Share by Regions
Table Global Growth Factors (Blood and Tissue) Revenue by Regions 2016-2025 (Million US$)
Table Global Growth Factors (Blood and Tissue) Revenue Market Share by Regions 2016-2025
Figure Global Growth Factors (Blood and Tissue) Revenue Market Share by Regions 2016-2025
Figure 2017 Global Growth Factors (Blood and Tissue) Revenue Market Share by Regions
Table Global Growth Factors (Blood and Tissue) Sales by Manufacturers (2016-2018) (MT)
Table Global Growth Factors (Blood and Tissue) Sales Share by Manufacturers (2016-2018)
Figure Global Growth Factors (Blood and Tissue) Sales Share by Manufacturers in 2017
Table Growth Factors (Blood and Tissue) Revenue by Manufacturers (2016-2018) (Million US$)
Table Growth Factors (Blood and Tissue) Revenue Share by Manufacturers (2016-2018)
Figure Growth Factors (Blood and Tissue) Value Share by Manufacturers in 2017
Table Global Growth Factors (Blood and Tissue) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Growth Factors (Blood and Tissue) Price (2016-2018) (USD/Kg)
Table Growth Factors (Blood and Tissue) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Growth Factors (Blood and Tissue) Product Category
Table Date of International Manufacturers Enter into Growth Factors (Blood and Tissue) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Growth Factors (Blood and Tissue) Sales by Type (2016-2025) (MT)
Table Global Growth Factors (Blood and Tissue) Sales Share by Type (2016-2025)
Figure Global Growth Factors (Blood and Tissue) Sales Market Share by Type (2016-2025)
Figure Global Growth Factors (Blood and Tissue) Sales Market Share by Type in 2017
Table Global Growth Factors (Blood and Tissue) Revenue by Type (2016-2025) (Million US$)
Table Global Growth Factors (Blood and Tissue) Revenue Share by Type (2016-2025)
Figure Global Growth Factors (Blood and Tissue) Revenue Market Share by Type (2016-2025)
Figure Global Growth Factors (Blood and Tissue) Revenue Market Share by Type in 2017
Table Growth Factors (Blood and Tissue) Price by Type 2013-2018 (USD/Kg)
Table Global Growth Factors (Blood and Tissue) Sales by Application (2016-2025) (MT)
Table Global Growth Factors (Blood and Tissue) Sales Share by Application (2016-2025)
Figure Global Sales Growth Factors (Blood and Tissue) Market Share by Application (2016-2025)
Figure Global Sales Growth Factors (Blood and Tissue) Market Share by Application (2016-2025)
Figure North America Growth Factors (Blood and Tissue) Sales Growth Rate 2016-2025 (MT)
Figure North America Growth Factors (Blood and Tissue) Revenue Growth Rate 2016-2025 (Million US$)
Table North America Growth Factors (Blood and Tissue) Sales by Countries (2016-2025) (MT)
Table North America Growth Factors (Blood and Tissue) Sales Market Share by Countries (2016-2025)
Figure 2017 North America Growth Factors (Blood and Tissue) Sales Market Share by Countries
Table North America Growth Factors (Blood and Tissue) Revenue by Countries (2016-2025) (Million US$)
Table North America Growth Factors (Blood and Tissue) Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Growth Factors (Blood and Tissue) Revenue Market Share by Countries
Figure United States Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure United States Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Canada Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Mexico Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Table North America Growth Factors (Blood and Tissue) Sales by Type (2016-2025) (MT)
Table North America Growth Factors (Blood and Tissue) Sales Market Share by Type (2016-2025)
Figure 2017 North America Growth Factors (Blood and Tissue) Market Share by Type
Table North America Growth Factors (Blood and Tissue) Sales by Application (2016-2025) (MT)
Table North America Growth Factors (Blood and Tissue) Sales Market Share by Application (2016-2025)
Figure 2017 North America Growth Factors (Blood and Tissue) Market Share by Application
Table North America Growth Factors (Blood and Tissue) Sales by Company (2016-2018) (MT)
Table North America Growth Factors (Blood and Tissue) Sales Market Share by Company (2016-2018)
Figure North America Growth Factors (Blood and Tissue) Sales Market Share by Company in 2017
Figure Europe Growth Factors (Blood and Tissue) Sales Growth Rate 2016-2025 (MT)
Figure Europe Growth Factors (Blood and Tissue) Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Growth Factors (Blood and Tissue) Sales by Countries (2016-2025) (MT)
Table Europe Growth Factors (Blood and Tissue) Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Growth Factors (Blood and Tissue) Sales Market Share by Countries
Table Europe Growth Factors (Blood and Tissue) Revenue by Countries (2016-2025) (Million US$)
Table Europe Growth Factors (Blood and Tissue) Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Growth Factors (Blood and Tissue) Revenue Market Share by Countries
Figure Germany Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Germany Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (MT)
Figure France Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure France Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (MT)
Figure UK Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure UK Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Italy Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Russia Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Growth Factors (Blood and Tissue) Sales by Type (2016-2025) (MT)
Table Europe Growth Factors (Blood and Tissue) Sales Market Share by Type (2016-2025)
Figure 2017 Europe Growth Factors (Blood and Tissue) Market Share by Type
Table Europe Growth Factors (Blood and Tissue) Sales by Application (2016-2025) (MT)
Table Europe Growth Factors (Blood and Tissue) Sales Market Share by Application (2016-2025)
Figure 2017 Europe Growth Factors (Blood and Tissue) Market Share by Application
Table Europe Growth Factors (Blood and Tissue) Sales by Company (2016-2018) (MT)
Table Europe Growth Factors (Blood and Tissue) Sales Market Share by Company (2016-2018)
Figure Europe Growth Factors (Blood and Tissue) Sales Market Share by Company in 2017
Figure Asia Pacific Growth Factors (Blood and Tissue) Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Growth Factors (Blood and Tissue) Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Growth Factors (Blood and Tissue) Sales by Countries (2016-2025) (MT)
Table Asia Pacific Growth Factors (Blood and Tissue) Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Growth Factors (Blood and Tissue) Sales Market Share by Countries
Table Asia Pacific Growth Factors (Blood and Tissue) Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Growth Factors (Blood and Tissue) Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Growth Factors (Blood and Tissue) Revenue Market Share by Countries
Figure China Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure China Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Japan Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Korea Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure India Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure India Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Australia Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Philippines Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Thailand Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Singapore Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Growth Factors (Blood and Tissue) Sales by Type (2016-2025) (MT)
Table Asia Pacific Growth Factors (Blood and Tissue) Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Growth Factors (Blood and Tissue) Market Share by Type
Table Asia Pacific Growth Factors (Blood and Tissue) Sales by Application (2016-2025) (MT)
Table Asia Pacific Growth Factors (Blood and Tissue) Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Growth Factors (Blood and Tissue) Market Share by Application
Table Asia Pacific Growth Factors (Blood and Tissue) Sales by Company (2016-2018) (MT)
Table Asia Pacific Growth Factors (Blood and Tissue) Sales Market Share by Company (2016-2018)
Figure Asia Pacific Growth Factors (Blood and Tissue) Sales Market Share by Company in 2017
Figure Central & South America Growth Factors (Blood and Tissue) Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Growth Factors (Blood and Tissue) Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Growth Factors (Blood and Tissue) Sales by Countries (2016-2025) (MT)
Table Central & South America Growth Factors (Blood and Tissue) Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Growth Factors (Blood and Tissue) Sales Market Share by Countries
Table Central & South America Growth Factors (Blood and Tissue) Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Growth Factors (Blood and Tissue) Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Growth Factors (Blood and Tissue) Revenue Market Share by Countries
Figure Brazil Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Brazil Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Argentina Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Growth Factors (Blood and Tissue) Sales by Type (2016-2025) (MT)
Table Central & South America Growth Factors (Blood and Tissue) Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Growth Factors (Blood and Tissue) Market Share by Type
Table Central & South America Growth Factors (Blood and Tissue) Sales by Application (2016-2025) (MT)
Table Central & South America Growth Factors (Blood and Tissue) Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Growth Factors (Blood and Tissue) Market Share by Application
Table Central & South America Growth Factors (Blood and Tissue) Sales by Company (2016-2018) (MT)
Table Central & South America Growth Factors (Blood and Tissue) Sales Market Share by Company (2016-2018)
Figure Central & South America Growth Factors (Blood and Tissue) Sales Market Share by Company in 2017
Figure Middle East and Africa Growth Factors (Blood and Tissue) Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Growth Factors (Blood and Tissue) Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Growth Factors (Blood and Tissue) Sales Market Share by Countries
Table Middle East and Africa Growth Factors (Blood and Tissue) Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Growth Factors (Blood and Tissue) Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Growth Factors (Blood and Tissue) Revenue Market Share by Countries
Figure GCC Countries Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Turkey Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure Egypt Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Growth Factors (Blood and Tissue) Sales Growth Rate (2016-2025) (MT)
Figure South Africa Growth Factors (Blood and Tissue) Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales by Type (2016-2025) (MT)
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Growth Factors (Blood and Tissue) Market Share by Type
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales by Application (2016-2025) (MT)
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Growth Factors (Blood and Tissue) Market Share by Application
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales by Company (2016-2018) (MT)
Table Middle East and Africa Growth Factors (Blood and Tissue) Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Growth Factors (Blood and Tissue) Sales Market Share by Company in 2017
Table Amgen, Inc. (USA) Company Details
Table Amgen, Inc. (USA) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Amgen, Inc. (USA) Recent Development
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Company Details
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Recent Development
Table Biocon Ltd. (India) Company Details
Table Biocon Ltd. (India) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Biocon Ltd. (India) Recent Development
Table Biogen, Inc. (USA) Company Details
Table Biogen, Inc. (USA) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Biogen, Inc. (USA) Recent Development
Table BioMimetic Therapeutics LLC (USA) Company Details
Table BioMimetic Therapeutics LLC (USA) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table BioMimetic Therapeutics LLC (USA) Recent Development
Table Biopharm GmbH (Germany) Company Details
Table Biopharm GmbH (Germany) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Biopharm GmbH (Germany) Recent Development
Table Bolder BioTechnology, Inc. (USA) Company Details
Table Bolder BioTechnology, Inc. (USA) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Bolder BioTechnology, Inc. (USA) Recent Development
Table F. Hoffmann-La Roche AG (Switzerland) Company Details
Table F. Hoffmann-La Roche AG (Switzerland) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche AG (Switzerland) Recent Development
Table Chugai Pharmaceutical Co. Ltd. (Japan) Company Details
Table Chugai Pharmaceutical Co. Ltd. (Japan) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Chugai Pharmaceutical Co. Ltd. (Japan) Recent Development
Table Genentech, Inc. (USA) Company Details
Table Genentech, Inc. (USA) Growth Factors (Blood and Tissue) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Genentech, Inc. (USA) Recent Development
Table FibroGen, Inc. (USA) Company Details
Table Johnson & Johnson (USA) Company Details
Table Janssen Biotech, Inc. (USA) Company Details
Table Lonza Group (Switzerland) Company Details
Table Merck Serono (Germany) Company Details
Table PeproTech, Inc. (USA) Company Details
Table Reliance GeneMedix Plc (UK) Company Details
Table Sangamo Therapeutics, Inc. (USA) Company Details
Table Sanofi (France) Company Details
Table Scil Proteins GmbH (Germany) Company Details
Table Teva Pharmaceutical Industries Ltd. (Israel) Company Details
Table Wockhardt Ltd. (India) Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Growth Factors (Blood and Tissue) Value Chain
Table Typical Suppliers of Key Growth Factors (Blood and Tissue) Raw Material
Table Growth Factors (Blood and Tissue) Customers List
Table Growth Factors (Blood and Tissue) Sales Channels
Table Growth Factors (Blood and Tissue) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *